Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nedelman

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Cellular Physiology|December 1, 1985
A stochastic model for mast cell proliferation in cultureP N Pharr, J Nedelman, H P Downs, et al.
Statistics in Medicine|March 1, 1991
Modelling length bias in a longitudinally-linked record system of HIV casesJ Nedelman, A Burns, J Cleary, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 2, 2022
Male reproductive hormones in patients treated with pretomanidK Boekelheide, M Olugbosi, J Nedelman, et al.
Journal of Traumatic Stress|January 3, 2022
Traumatic stress symptoms predict restraint incidents in children and adolescents in psychiatric residential treatmentWilson J Brown, Anthony J Nedelman, William G Phillips, et al.
Biopharmaceutics & Drug Disposition|March 1, 1997
The effect of food on the pharmacokinetics of multiple-dose terbinafine in young and elderly healthy subjectsJ Nedelman, J A Cramer, B Robbins, et al.
Journal of Clinical Pharmacology|September 1, 1995
Efficacy and pharmacokinetics of two formulations of cyclosporine A in patients with psoriasisC A Elder, M Moore, C T Chang, et al.
IJTLD Open|August 18, 2025
Hepatic safety of pretomanid- and pyrazinamide-containing regimens in TB Alliance clinical trialsJ Nedelman, M Li, M Olugbosi, et al.
Trials|January 6, 2026
Protocol for a phase 2, partially blinded, randomized trial assessing the safety and efficacy of sorfequiline or bedaquiline in combination with pretomanid and linezolid in adult participants with newly diagnosed, drug-sensitive, smear-positive pulmonary tuberculosis (NC-009)M Olugbosi, M Beumont, L Lombard, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Cellular Physiology|December 1, 1985
A stochastic model for mast cell proliferation in cultureP N Pharr, J Nedelman, H P Downs, et al.
Statistics in Medicine|March 1, 1991
Modelling length bias in a longitudinally-linked record system of HIV casesJ Nedelman, A Burns, J Cleary, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 2, 2022
Male reproductive hormones in patients treated with pretomanidK Boekelheide, M Olugbosi, J Nedelman, et al.
Journal of Traumatic Stress|January 3, 2022
Traumatic stress symptoms predict restraint incidents in children and adolescents in psychiatric residential treatmentWilson J Brown, Anthony J Nedelman, William G Phillips, et al.
Biopharmaceutics & Drug Disposition|March 1, 1997
The effect of food on the pharmacokinetics of multiple-dose terbinafine in young and elderly healthy subjectsJ Nedelman, J A Cramer, B Robbins, et al.
Journal of Clinical Pharmacology|September 1, 1995
Efficacy and pharmacokinetics of two formulations of cyclosporine A in patients with psoriasisC A Elder, M Moore, C T Chang, et al.
IJTLD Open|August 18, 2025
Hepatic safety of pretomanid- and pyrazinamide-containing regimens in TB Alliance clinical trialsJ Nedelman, M Li, M Olugbosi, et al.
Trials|January 6, 2026
Protocol for a phase 2, partially blinded, randomized trial assessing the safety and efficacy of sorfequiline or bedaquiline in combination with pretomanid and linezolid in adult participants with newly diagnosed, drug-sensitive, smear-positive pulmonary tuberculosis (NC-009)M Olugbosi, M Beumont, L Lombard, et al.
Pageof 2